Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study
NCT06017141 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2023-08-30
Summary
This trial evaluates how inhalational anesthesia (drawn in through the lungs) and total intravenous anesthesia (TIVA) (through a needle in a vein in the arm) change the body's ability to recover from surgery or whether they impact the immune system immediately after surgery in patients with colon cancer. It is unknown whether these types of anesthesia change recovery from surgery or change the chances cancer comes back following surgery. This study may help researchers learn how different types of anesthesia affect recovery from colon cancer surgery.
Conditions
- Colon Adenocarcinoma
Interventions
- PROCEDURE
-
Biospecimen Collection
Undergo blood and tissue sample collection
- OTHER
-
Electronic Health Record Review
Ancillary studies
- DRUG
-
Fentanyl Citrate
Given via injection
- DRUG
-
Propofol
Given IV
- OTHER
-
Questionnaire Administration
Ancillary studies
- DRUG
-
Sevoflurane
Given via inhalation
- PROCEDURE
-
Surgical Procedure
Undergo SOC surgery
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Kansas Medical Center
lead OTHER
Principal Investigators
-
Luke V Selby · University of Kansas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-05-22
- Primary Completion
- 2025-05-22
- Completion
- 2026-05-22
Countries
- United States
Study Locations
More Related Trials
-
S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
NCT00002593 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed
NCT00002525 ·Status: TERMINATED ·Phase: PHASE3
-
Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
NCT00006015 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver
NCT00006050 ·Status: COMPLETED ·Phase: PHASE2
-
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
NCT00385021 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
NCT00039611 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Patients With Colorectal Cancer
NCT00006103 ·Status: COMPLETED ·Phase: PHASE3
-
Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors
NCT00138177 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
NCT00002692 ·Status: UNKNOWN ·Phase: PHASE3
-
Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer
NCT00336141 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer
NCT00201331 ·Status: UNKNOWN ·Phase: PHASE2
-
Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
NCT00016952 ·Status: COMPLETED ·Phase: PHASE2
-
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
NCT00096278 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile
NCT01472601 ·Status: UNKNOWN
-
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
NCT06501989 ·Status: WITHDRAWN ·Phase: PHASE2
-
Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
NCT00425152 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
NCT00192075 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer
NCT02141295 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
NCT00065117 ·Status: TERMINATED ·Phase: PHASE2
-
Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery
NCT03317119 ·Status: COMPLETED ·Phase: PHASE1
-
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
NCT01238939 ·Status: COMPLETED ·Phase: PHASE1
-
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
NCT00004931 ·Status: COMPLETED ·Phase: PHASE3
-
Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery
NCT00427310 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
NCT01260415 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
NCT05669521 ·Status: UNKNOWN ·Phase: PHASE2